AssayIndex
QYB cross-section

QYB by compound

QYB records split by compound, with the index-wide comparison for the same compound beside each one. 23 compounds, 236 records. Cells below n=3 print their raw values instead of a median.

23 compounds236 records
CompoundClassReportsQYB median %Index median %Δ (pp)SpecPass %
BPC-157Tissue-repair3099.9099.16+0.7498.0100
RetatrutideIncretin2898.4798.37+0.0996.5100
GHRP-6Growth-hormone2799.4899.54-0.0699.096
TirzepatideIncretin2299.2598.55+0.7097.0100
SemaglutideIncretin1899.3898.89+0.4997.0100
N-Acetyl Semax AmideNeuroactive1499.7299.35+0.3798.5100
OxytocinHypothalamic1299.6999.81-0.1398.5100
Thymosin α1Tissue-repair1299.7699.40+0.3697.5100
AOD-9604Metabolic1299.5299.29+0.2398.0100
GHRP-2Growth-hormone1099.0599.28-0.2399.070
IpamorelinGrowth-hormone999.9399.47+0.4699.0100
Humanin (HNG)Metabolic999.2799.12+0.1597.5100
SermorelinGrowth-hormone999.5599.06+0.4998.0100
PT-141 (Bremelanotide)Melanocortin-receptor5 n=599.7299.38+0.3498.5100
TB-500Tissue-repair5 n=599.9099.53+0.3798.5100
ARA-290Tissue-repair3 n=399.6699.42+0.2498.0100
PemvidutideIncretin2 n=2n<398.2596.0100
MK-677 (Ibutamoren mesylate)Non-peptide2 n=2n<399.4998.5100
SelankNeuroactive2 n=2n<399.5999.0100
Melanotan IIMelanocortin-receptor2 n=2n<399.4298.5100
LiraglutideIncretin1 n=1n<399.0097.5100
SS-31 (Elamipretide)Metabolic1 n=1n<399.5398.5100
CJC-1295 (no DAC)Growth-hormone1 n=1n<399.0998.0100
97.698.098.498.899.399.7100.1BPC-157BPC-157: Q1 99.75, median 99.90, Q3 99.93, n=30outlier 99.37outlier 99.47n=30RetatrutideRetatrutide: Q1 98.29, median 98.47, Q3 98.63, n=28outlier 97.75outlier 99.36outlier 99.52n=28GHRP-6GHRP-6: Q1 99.33, median 99.48, Q3 99.69, n=27n=27TirzepatideTirzepatide: Q1 99.10, median 99.25, Q3 99.36, n=22outlier 98.68n=22SemaglutideSemaglutide: Q1 99.20, median 99.38, Q3 99.68, n=18n=18N-Acetyl Semax AmideN-Acetyl Semax Amide: Q1 99.64, median 99.72, Q3 99.93, n=14n=14OxytocinOxytocin: Q1 99.62, median 99.69, Q3 99.83, n=12n=12Thymosin α1Thymosin α1: Q1 99.57, median 99.76, Q3 99.81, n=12n=12AOD-9604AOD-9604: Q1 99.34, median 99.52, Q3 99.66, n=12n=12GHRP-2GHRP-2: Q1 98.97, median 99.05, Q3 99.28, n=10n=10IpamorelinIpamorelin: Q1 99.84, median 99.93, Q3 99.93, n=9outlier 99.67n=9Humanin (HNG)Humanin (HNG): Q1 99.13, median 99.27, Q3 99.32, n=9n=9SermorelinSermorelin: Q1 99.28, median 99.55, Q3 99.65, n=9n=9PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.58, median 99.72, Q3 99.77, n=5outlier 99.16n=5 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines QYB actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. ChinaPeptides Co., Ltd. (QYAOBIO) lists considerably more than the 23 compounds above. Of those 23, 18 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the QYB catalogue at qyaobiopeptides.com →